Research Article

Normal and Reversed-Phase HPTLC Methods for Simultaneous Estimation of Telmisartan and Metoprolol Succinate in Pharmaceutical Formulation

Table 1

Analysis of tablet formulation.

MethodDrugLabel claim (mg)% Amount found% RSD ( 𝑛 = 5 )

ITELMI4099.180.62
MET5099.690.96

IITELMI4098.550.88
MET5099.120.64